“… Hahn, a radiation oncologist who is now CEO of the University of Texas M.D. Anderson Cancer Center in Houston, would replace Dr. Scott Gottlieb, who resigned in March.”
- How will he handle the vaping crisis?
- What’s next for patients in need of treatment for pain?
- Is running an academic medical center similar to running a government agency?
- What’s his view on cannabis?
- What’s his thinking on modernizing the FDA approval process?…” Read the full article here.
Source: Five things you should know about Stephen Hahn, Trump’s nominee to head FDA – By Jaimy Lee, November 21, 2019. MarketWatch.
